Ditrolense Ripe (Cefditoren Pivoxil)

Child dose

Pneumonia, otitis media, sinusitis: Administer 3 mg (potency)/kg of cefditoren pivoxil orally 3 times daily after meals. If necessary, the dose may be increased to 6 mg (potency)/kg per dose. The dose may be adjusted as appropriate according to age and symptoms, but do not exceed 200mg (potency) per dose 3 times daily (600mg (potency) daily). Conditions other than pneumonia, otitis media, and sinusitis: Administer 3 mg (potency)/kg of cefditoren pivoxil orally 3 times daily after meals. The dose may be adjusted as appropriate according to age and symptoms, but do not exceed 200mg (potency) per dose 3 times daily (600mg (potency) daily).

This medication contains the artificial sweetener aspartame, which is broken down into phenylalanine in the body. Therefore, patients with the genetic disorder phenylketonuria should not take this medication. This medication contains milk proteins and lactose, so patients with milk allergies or lactose intolerance should also avoid it. Additionally, patients with a history of shock due to this medication or its components or those with carnitine deficiency should not be administered this medication. Patients who have previously shown allergic reactions to this medication or similar antibiotics, as well as those with a family history of allergies, should use this medication cautiously. Care is also necessary for patients with severely impaired kidney function, elderly patients, or those in poor general condition. This medication can rarely cause serious allergic reactions, liver or kidney function abnormalities, severe colitis, and mucocutaneous syndrome, so if abnormal symptoms occur, discontinue use immediately and consult a physician. This medication may interact with other drugs, so it is not recommended to take it with antacids or certain gastrointestinal medications. Additionally, the safety of this medication has not been established for pregnant or nursing women, so it should be used cautiously only when necessary. Safety has not been sufficiently verified for children, particularly premature infants or newborns, and elderly patients may have elevated drug levels due to decreased kidney function, so dosing intervals should be adjusted. When taking this medication, it should be stored out of reach of children, kept away from moisture and light, and the prescribed dosage and regimen must be followed. Regular monitoring for adverse reactions during the use of this medication is also important.

• Shock
• anaphylaxis
• discomfort
• oral dysesthesia
• asthma
• dizziness
• diarrhea
• tinnitus
• sweating
• wheezing

This medication may be sensitive to light, so it should be stored in a light-blocking, tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance

A pale yellow to light yellow granular preparation with a slightly unusual odor.

Package unit

50 grams/bottle